The Oral Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Oral Vaccines market size is estimated to be worth US$ 2545.6 million in 2021 and is forecast to a readjusted size of USD 3375.9 million by 2028 with a CAGR of 4.1% during review period. Public accounting for % of the Oral Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Rotavirus Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, and Serum Institute, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Market segment by Application can be divided into
Public
Private
The key market players for global Oral Vaccines market are listed below:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Vaccines, with price, sales, revenue and global market share of Oral Vaccines from 2019 to 2022.
Chapter 3, the Oral Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Vaccines.
Chapter 13, 14, and 15, to describe Oral Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Oral Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Public
1.3.3 Private
1.4 Global Oral Vaccines Market Size & Forecast
1.4.1 Global Oral Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Vaccines Sales in Volume (2017-2028)
1.4.3 Global Oral Vaccines Price (2017-2028)
1.5 Global Oral Vaccines Production Capacity Analysis
1.5.1 Global Oral Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Oral Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Vaccines Market Drivers
1.6.2 Oral Vaccines Market Restraints
1.6.3 Oral Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Oral Vaccines Product and Services
2.1.4 Merck Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Oral Vaccines Product and Services
2.2.4 GSK Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Oral Vaccines Product and Services
2.3.4 Sanofi Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lanzhou Institute
2.4.1 Lanzhou Institute Details
2.4.2 Lanzhou Institute Major Business
2.4.3 Lanzhou Institute Oral Vaccines Product and Services
2.4.4 Lanzhou Institute Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Serum Institute
2.5.1 Serum Institute Details
2.5.2 Serum Institute Major Business
2.5.3 Serum Institute Oral Vaccines Product and Services
2.5.4 Serum Institute Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Valneva
2.6.1 Valneva Details
2.6.2 Valneva Major Business
2.6.3 Valneva Oral Vaccines Product and Services
2.6.4 Valneva Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shanghai United Cell
2.7.1 Shanghai United Cell Details
2.7.2 Shanghai United Cell Major Business
2.7.3 Shanghai United Cell Oral Vaccines Product and Services
2.7.4 Shanghai United Cell Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bibcol
2.8.1 Bibcol Details
2.8.2 Bibcol Major Business
2.8.3 Bibcol Oral Vaccines Product and Services
2.8.4 Bibcol Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 PaxVax
2.9.1 PaxVax Details
2.9.2 PaxVax Major Business
2.9.3 PaxVax Oral Vaccines Product and Services
2.9.4 PaxVax Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Vabiotech
2.10.1 Vabiotech Details
2.10.2 Vabiotech Major Business
2.10.3 Vabiotech Oral Vaccines Product and Services
2.10.4 Vabiotech Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Tiantan Biological
2.11.1 Tiantan Biological Details
2.11.2 Tiantan Biological Major Business
2.11.3 Tiantan Biological Oral Vaccines Product and Services
2.11.4 Tiantan Biological Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 EuBiologics
2.12.1 EuBiologics Details
2.12.2 EuBiologics Major Business
2.12.3 EuBiologics Oral Vaccines Product and Services
2.12.4 EuBiologics Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Panacea Biotec Ltd
2.13.1 Panacea Biotec Ltd Details
2.13.2 Panacea Biotec Ltd Major Business
2.13.3 Panacea Biotec Ltd Oral Vaccines Product and Services
2.13.4 Panacea Biotec Ltd Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Bio-Med
2.14.1 Bio-Med Details
2.14.2 Bio-Med Major Business
2.14.3 Bio-Med Oral Vaccines Product and Services
2.14.4 Bio-Med Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Halfkin Bio-Pharmaceuticals
2.15.1 Halfkin Bio-Pharmaceuticals Details
2.15.2 Halfkin Bio-Pharmaceuticals Major Business
2.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
2.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oral Vaccines Breakdown Data by Manufacturer
3.1 Global Oral Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Vaccines Manufacturer Market Share in 2021
3.5 Global Oral Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Vaccines Market Size by Region
4.1.1 Global Oral Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Vaccines Revenue by Region (2017-2028)
4.2 North America Oral Vaccines Revenue (2017-2028)
4.3 Europe Oral Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Oral Vaccines Revenue (2017-2028)
4.5 South America Oral Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Oral Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oral Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Oral Vaccines Revenue by Type (2017-2028)
5.3 Global Oral Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oral Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Oral Vaccines Revenue by Application (2017-2028)
6.3 Global Oral Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oral Vaccines Sales by Type (2017-2028)
7.2 North America Oral Vaccines Sales by Application (2017-2028)
7.3 North America Oral Vaccines Market Size by Country
7.3.1 North America Oral Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Vaccines Sales by Type (2017-2028)
8.2 Europe Oral Vaccines Sales by Application (2017-2028)
8.3 Europe Oral Vaccines Market Size by Country
8.3.1 Europe Oral Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oral Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Vaccines Market Size by Region
9.3.1 Asia-Pacific Oral Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oral Vaccines Sales by Type (2017-2028)
10.2 South America Oral Vaccines Sales by Application (2017-2028)
10.3 South America Oral Vaccines Market Size by Country
10.3.1 South America Oral Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Vaccines Market Size by Country
11.3.1 Middle East & Africa Oral Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oral Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Vaccines
12.3 Oral Vaccines Production Process
12.4 Oral Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Vaccines Typical Distributors
13.3 Oral Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Oral Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Oral Vaccines Product and Services
Table 6. Merck Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Oral Vaccines Product and Services
Table 10. GSK Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Oral Vaccines Product and Services
Table 14. Sanofi Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 16. Lanzhou Institute Major Business
Table 17. Lanzhou Institute Oral Vaccines Product and Services
Table 18. Lanzhou Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute Major Business
Table 21. Serum Institute Oral Vaccines Product and Services
Table 22. Serum Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Valneva Basic Information, Manufacturing Base and Competitors
Table 24. Valneva Major Business
Table 25. Valneva Oral Vaccines Product and Services
Table 26. Valneva Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 28. Shanghai United Cell Major Business
Table 29. Shanghai United Cell Oral Vaccines Product and Services
Table 30. Shanghai United Cell Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bibcol Basic Information, Manufacturing Base and Competitors
Table 32. Bibcol Major Business
Table 33. Bibcol Oral Vaccines Product and Services
Table 34. Bibcol Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. PaxVax Basic Information, Manufacturing Base and Competitors
Table 36. PaxVax Major Business
Table 37. PaxVax Oral Vaccines Product and Services
Table 38. PaxVax Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 40. Vabiotech Major Business
Table 41. Vabiotech Oral Vaccines Product and Services
Table 42. Vabiotech Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 44. Tiantan Biological Major Business
Table 45. Tiantan Biological Oral Vaccines Product and Services
Table 46. Tiantan Biological Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 48. EuBiologics Major Business
Table 49. EuBiologics Oral Vaccines Product and Services
Table 50. EuBiologics Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Panacea Biotec Ltd Major Business
Table 53. Panacea Biotec Ltd Oral Vaccines Product and Services
Table 54. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 56. Bio-Med Major Business
Table 57. Bio-Med Oral Vaccines Product and Services
Table 58. Bio-Med Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Halfkin Bio-Pharmaceuticals Major Business
Table 61. Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
Table 62. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Oral Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 64. Global Oral Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Oral Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Oral Vaccines Production Capacity by Company, (M Doses): 2020 VS 2021
Table 67. Head Office and Oral Vaccines Production Site of Key Manufacturer
Table 68. Oral Vaccines New Entrant and Capacity Expansion Plans
Table 69. Oral Vaccines Mergers & Acquisitions in the Past Five Years
Table 70. Global Oral Vaccines Sales by Region (2017-2022) & (M Doses)
Table 71. Global Oral Vaccines Sales by Region (2023-2028) & (M Doses)
Table 72. Global Oral Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Oral Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 75. Global Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 76. Global Oral Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Oral Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Oral Vaccines Price by Type (2017-2022) & (USD/K Doses)
Table 79. Global Oral Vaccines Price by Type (2023-2028) & (USD/K Doses)
Table 80. Global Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 81. Global Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 82. Global Oral Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Oral Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Oral Vaccines Price by Application (2017-2022) & (USD/K Doses)
Table 85. Global Oral Vaccines Price by Application (2023-2028) & (USD/K Doses)
Table 86. North America Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 87. North America Oral Vaccines Sales by Country (2023-2028) & (M Doses)
Table 88. North America Oral Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Oral Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 91. North America Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 92. North America Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 93. North America Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 94. Europe Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 95. Europe Oral Vaccines Sales by Country (2023-2028) & (M Doses)
Table 96. Europe Oral Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Oral Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 99. Europe Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 100. Europe Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 101. Europe Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 102. Asia-Pacific Oral Vaccines Sales by Region (2017-2022) & (M Doses)
Table 103. Asia-Pacific Oral Vaccines Sales by Region (2023-2028) & (M Doses)
Table 104. Asia-Pacific Oral Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Oral Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 107. Asia-Pacific Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 108. Asia-Pacific Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 109. Asia-Pacific Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 110. South America Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 111. South America Oral Vaccines Sales by Country (2023-2028) & (M Doses)
Table 112. South America Oral Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Oral Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 115. South America Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 116. South America Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 117. South America Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 118. Middle East & Africa Oral Vaccines Sales by Region (2017-2022) & (M Doses)
Table 119. Middle East & Africa Oral Vaccines Sales by Region (2023-2028) & (M Doses)
Table 120. Middle East & Africa Oral Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Oral Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 123. Middle East & Africa Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 124. Middle East & Africa Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 125. Middle East & Africa Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 126. Oral Vaccines Raw Material
Table 127. Key Manufacturers of Oral Vaccines Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Oral Vaccines Typical Distributors
Table 131. Oral Vaccines Typical Customers
List of Figures
Figure 1. Oral Vaccines Picture
Figure 2. Global Oral Vaccines Revenue Market Share by Type in 2021
Figure 3. Rotavirus Vaccine
Figure 4. Cholera Vaccine
Figure 5. Oral Polio Vaccine
Figure 6. Global Oral Vaccines Revenue Market Share by Application in 2021
Figure 7. Public
Figure 8. Private
Figure 9. Global Oral Vaccines Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 10. Global Oral Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Oral Vaccines Sales (2017-2028) & (M Doses)
Figure 12. Global Oral Vaccines Price (2017-2028) & (USD/K Doses)
Figure 13. Global Oral Vaccines Production Capacity (2017-2028) & (M Doses)
Figure 14. Global Oral Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Oral Vaccines Market Drivers
Figure 16. Oral Vaccines Market Restraints
Figure 17. Oral Vaccines Market Trends
Figure 18. Global Oral Vaccines Sales Market Share by Manufacturer in 2021
Figure 19. Global Oral Vaccines Revenue Market Share by Manufacturer in 2021
Figure 20. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Oral Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Oral Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Oral Vaccines Sales Market Share by Region (2017-2028)
Figure 24. Global Oral Vaccines Revenue Market Share by Region (2017-2028)
Figure 25. North America Oral Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Europe Oral Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Oral Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. South America Oral Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Oral Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Global Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Oral Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Oral Vaccines Price by Type (2017-2028) & (USD/K Doses)
Figure 33. Global Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 34. Global Oral Vaccines Revenue Market Share by Application (2017-2028)
Figure 35. Global Oral Vaccines Price by Application (2017-2028) & (USD/K Doses)
Figure 36. North America Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 37. North America Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 38. North America Oral Vaccines Sales Market Share by Country (2017-2028)
Figure 39. North America Oral Vaccines Revenue Market Share by Country (2017-2028)
Figure 40. United States Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 44. Europe Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Oral Vaccines Sales Market Share by Country (2017-2028)
Figure 46. Europe Oral Vaccines Revenue Market Share by Country (2017-2028)
Figure 47. Germany Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Oral Vaccines Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Oral Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Oral Vaccines Revenue Market Share by Region (2017-2028)
Figure 56. China Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 63. South America Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 64. South America Oral Vaccines Sales Market Share by Country (2017-2028)
Figure 65. South America Oral Vaccines Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Oral Vaccines Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Oral Vaccines Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Oral Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Oral Vaccines in 2021
Figure 77. Manufacturing Process Analysis of Oral Vaccines
Figure 78. Oral Vaccines Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source